That's exciting research! Yale scientists are using zebrafish to screen potential autism drug candidates more efficiently—they share about 62% of human autism-related genes (PMC9329562). Their transparent embryos allow real-time study of brain development, and studies like PNAS show specific gene mutations (like Chd8) replicate autism-like social deficits. Early findings even suggest oxytocin may improve social behavior in zebrafish models (PMC9922369). This precision approach could lead to tailored therapies. The Simons Foundation supports this work—you can explore their zebrafish resources at sfari.org. While still in early stages, this pipeline accelerates translating genetic insights into testable treatments.